|
⚲
|
| Keyboard |
| Unkart Edward W
✚
|
|
|---|---|
| CIK # | 0001306267 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001306267] | |
| 4 | [0001306267] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Unkart Edward W | |
| KalVista Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2025-10-01 | Grant | 30,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (Right to Buy) · derivative
|
2024-10-03 | Grant | 10,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2023-09-26 | Grant | 10,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Employee Stock Option (right to buy) · derivative
|
2022-10-13 | Grant | 10,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Director Stock Option (Right to Buy) · derivative
|
2021-09-30 | Grant | 10,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Director Stock Option (right to buy) · derivative
|
2020-10-01 | Grant | 7,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Director Stock Option (Right to Buy) · derivative
|
2019-10-02 | Grant | 7,000 | $11.21 | 78,470 |
|
KalVista Pharmaceuticals Inc KALV
Director Stock Option (Right to Buy) · derivative
|
2018-10-03 | Grant | 7,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Director Stock Option (Right to Buy) · derivative
|
2017-09-27 | Grant | 6,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Director Stock Option (Right to Buy) · derivative
|
2017-03-23 | Grant | 12,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc CBYL
Stock Option (Right to Buy) · derivative
|
2015-08-03 | Grant | 29,000 | $0.00 |